Blood lactate monitoring in critically ill patients: A systematic health technology assessment*
- 1 October 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 37 (10), 2827-2839
- https://doi.org/10.1097/ccm.0b013e3181a98899
Abstract
To decide whether the use of blood lactate monitoring in critical care practice is appropriate. We performed a systematic health technology assessment as blood lactate monitoring has been implemented widely but its clinical value in critically ill patients has never been evaluated properly. PubMed, other databases, and citation review. We searched for lactate combined with critically ill patients as the target patient population. Two reviewers independently selected studies based on relevance for the following questions: Does lactate measurement: 1) perform well in a laboratory setting? 2) provide information in a number of clinical situations? 3) relate to metabolic acidosis? 4) increase workers' confidence? 5) alter therapeutic decisions? 6) result in benefit to patients? 7) result in similar benefits in your own setting? 8) result in benefits which are worth the extra costs? We concluded that blood lactate measurement in critically ill patients: 1) is accurate in terms of measurement technique but adequate understanding of the (an)aerobic etiology is required for its correct interpretation; 2) provides not only diagnostic but also important prognostic information; 3) should be measured directly instead of estimated from other acid-base variables; 4) has an unknown effect on healthcare workers' confidence; 5) can alter therapeutic decisions; 6) could potentially improve patient outcome when combined with a treatment algorithm to optimize oxygen delivery, but this has only been shown indirectly; 7) is likely to have similar benefits in critical care settings worldwide; and 8) has an unknown cost-effectiveness. The use of blood lactate monitoring has a place in risk-stratification in critically ill patients, but it is unknown whether the routine use of lactate as a resuscitation end point improves outcome. This warrants randomized controlled studies on the efficacy of lactate-directed therapy.Keywords
This publication has 94 references indexed in Scilit:
- The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814–1869) in January 1843Intensive Care Medicine, 2007
- Serum Lactate as a Predictor of Mortality in Emergency Department Patients with InfectionAnnals of Emergency Medicine, 2005
- Unmeasured anions in critically ill patients: Can they predict mortality?*Critical Care Medicine, 2003
- Role of skeletal muscle Na+–K+ ATPase activity in increased lactate production in sub–acute sepsisLife Sciences, 2002
- Stationsbezogenes Labor-Monitoring auf der Intensivstation - Blutgas-, Elektrolyt-, Glucose-, Hämoglobin- und Lactat-Bestimmungen mit dem CIBA-Corning 865 Analyse-SystemAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1997
- Lactic acidosis in sepsis: a commentaryIntensive Care Medicine, 1996
- Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsisCritical Care Medicine, 1995
- Randomized Evaluation of Pulse Oximetry in 20,802 Patients; IAnesthesiology, 1993
- Anionenlücke - ein Screening auf Hyperlaktatämie bei kritisch kranken Kindern?Klinische Padiatrie, 1992
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986